These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35260331)

  • 21. Outcome prognostic factors in inoperable malignant bowel obstruction.
    Romeo M; de Los LLanos Gil M; Cuadra Urteaga JL; Vilà L; Ahlal S; Indacochea A; Pardo N; Radua J; Font A; Tuca A
    Support Care Cancer; 2016 Nov; 24(11):4577-86. PubMed ID: 27286874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction.
    Chouhan J; Gupta R; Ensor J; Raghav K; Fogelman D; Wolff RA; Fisch M; Overman MJ
    Cancer Med; 2016 Feb; 5(2):239-47. PubMed ID: 26714799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival analysis of a prospective multicenter observational study on surgical palliation among patients with malignant bowel obstruction caused by peritoneal dissemination of gastric cancer.
    Kawabata R; Fujitani K; Sakamaki K; Ando M; Ito Y; Tanizawa Y; Yamada T; Hirao M; Yamada M; Hihara J; Ryoji ; Fukushima ; Choda Y; Kodera Y; Teshima S; Shinohara H; Kondo M; Yoshida K
    Gastric Cancer; 2022 Mar; 25(2):422-429. PubMed ID: 34550490
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Octreotide prescribing patterns in the palliation of symptomatic inoperable malignant bowel obstruction patients at a single US academic hospital.
    Hwang M; Pirrello R; Pu M; Messer K; Roeland E
    Support Care Cancer; 2013 Oct; 21(10):2817-24. PubMed ID: 23732621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of palliative bowel surgery for malignant bowel obstruction in patients with gynecological malignancy.
    Goto T; Takano M; Aoyama T; Miyamoto M; Watanabe A; Kato M; Sasaki N; Hirata J; Sasa H; Furuya K
    Oncol Lett; 2012 Nov; 4(5):883-888. PubMed ID: 23162616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant bowel obstruction in advanced ovarian cancer.
    Dean E; Khoja L; Clamp A; Jayson GC; Goonetilleke D; Conway AM; Hasan J
    Future Oncol; 2017 Mar; 13(6):513-521. PubMed ID: 28095701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resection of peritoneal metastases causing malignant small bowel obstruction.
    Abbas SM; Merrie AE
    World J Surg Oncol; 2007 Oct; 5():122. PubMed ID: 17958911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of decompression tubes with metallic stents for the management of right-sided malignant colonic obstruction.
    Suzuki Y; Moritani K; Seo Y; Takahashi T
    World J Gastroenterol; 2019 Apr; 25(16):1975-1985. PubMed ID: 31086465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer.
    Rath KS; Loseth D; Muscarella P; Phillips GS; Fowler JM; O'Malley DM; Cohn DE; Copeland LJ; Eisenhauer EL; Salani R
    Gynecol Oncol; 2013 Apr; 129(1):103-6. PubMed ID: 23369942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hospital utilization and disposition among patients with malignant bowel obstruction: a population-based comparison of surgical to medical management.
    Bateni SB; Gingrich AA; Stewart SL; Meyers FJ; Bold RJ; Canter RJ
    BMC Cancer; 2018 Nov; 18(1):1166. PubMed ID: 30477454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palliative surgery for colorectal cancer with peritoneal metastasis: a propensity-score matching analysis.
    Jeong SJ; Yoon YS; Lee JB; Lee JL; Kim CW; Park IJ; Lim SB; Yu CS; Kim JC
    Surg Today; 2017 Feb; 47(2):159-165. PubMed ID: 27549772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study.
    Ito Y; Fujitani K; Sakamaki K; Ando M; Kawabata R; Tanizawa Y; Yoshikawa T; Yamada T; Hirao M; Yamada M; Hihara J; Fukushima R; Choda Y; Kodera Y; Teshima S; Shinohara H; Kondo M
    Gastric Cancer; 2021 Sep; 24(5):1131-1139. PubMed ID: 33791885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
    Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS
    Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of patients with malignant bowel obstruction and stage IV colorectal cancer.
    Dalal KM; Gollub MJ; Miner TJ; Wong WD; Gerdes H; Schattner MA; Jaques DP; Temple LK
    J Palliat Med; 2011 Jul; 14(7):822-8. PubMed ID: 21595546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comprehensive Diagnosis and Management of Malignant Bowel Obstruction: A Review.
    Demarest K; Lavu H; Collins E; Batra V
    J Pain Palliat Care Pharmacother; 2023 Mar; 37(1):91-105. PubMed ID: 36377820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric cancer with peritoneal metastases: Efficiency of standard treatment methods.
    Yarema R; Оhorchak М; Hyrya P; Kovalchuk Y; Safiyan V; Karelin I; Ferneza S; Fetsych M; Matusyak M; Oliynyk Y; Fetsych Т
    World J Gastrointest Oncol; 2020 May; 12(5):569-581. PubMed ID: 32461788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term results of self-expanding metal stents for acute malignant large bowel obstruction.
    Kobborg M; Broholm M; Frostberg E; Jeppesen M; Gögenür I
    Colorectal Dis; 2017 Oct; 19(10):O365-O371. PubMed ID: 28892247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of adverse surgical outcome in the management of malignant bowel obstruction.
    Medina-Franco H; García-Alvarez MN; Ortiz-López LJ; Cuairán JZ
    Rev Invest Clin; 2008; 60(3):212-6. PubMed ID: 18807733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral water soluble contrast for malignant bowel obstruction.
    Syrmis W; Richard R; Jenkins-Marsh S; Chia SC; Good P
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012014. PubMed ID: 29513393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.